IBC Definitions and FAQs
Recombinant DNA—Molecules that are constructed outside living cells by joining a natural or synthetic DNA segment to DNA molecules that can replicate a living cell, or molecules that result from the replication of those described above.
Infectious agents—Organisms able to cause human disease. Examples include Escherichia coli (E. coli), Listeria, Salmonella, Hepatitis viruses.
Human blood, tissue or fluids—Blood is defined as human blood, human blood components, and products made from human blood. Other potentially infectious materials (OPIM) is defined as the following human body fluids: saliva in dental procedures, semen, vaginal secretions, cerebrospinal, synovial, pleural, pericardial, peritoneal, and amniotic fluids; body fluids visibly contaminated with blood; along with all body fluids in situations where it is difficult or impossible to differentiate between body fluids; unfixed human tissues or organs (other than intact skin); HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBV-containing culture media or other solutions; and blood, organs, or other tissues from experimental animals infected with HIV or HBV according to OSHA's Bloodborne Standard 1901.1030.
FAQs (Frequently Asked Questions)
What Projects Must Be Submitted for IBC Review?
All research and teaching projects conducted at NDSU by an NDSU representative or affiliated member that involves recombinant DNA, any infectious agents, or human blood, bodily fluids, or tissue must be submitted to the NDSU IBC for review and approval.
When & Where Must Projects Be Submitted?
Project directors of any research or teaching that uses recombinant DNA, infectious agents, or human blood, bodily fluids, or tissues must submit a completed "IBC Protocol Form" to the IBC in the Office of Sponsored Programs Administration, 1735 NDSU Research Park Drive, for review and approval before beginning the project.